APAC Contraceptives Market 2023 Share, Size, Key Players, Revenue Analysis | Prudent Markets

The APAC Contraceptives Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global APAC Contraceptives market. This report explores all the key factors affecting the growth of the global APAC Contraceptives market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141756/

Report Description of the APAC Contraceptives Market Analysis

Research Scope and Assumption

The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)

The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis

We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses

All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis

Inflation has not been accounted for in order to estimate and forecast the market

Numbers may not add up due to rounding off

Reason to buy the report:

Facilitate decision-making based on strong current and forecast data for APAC Contraceptives Market Analysis

Develop strategies based on the latest regulatory framework

Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market

Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC Contraceptives Market Analysis

Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders

To strategically profile key players and comprehensively analyze their market shares and core competencies

We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC Contraceptives Market Analysis Executive Summary

Contraception is a method of preventing pregnancy using drugs or a device. It is also known as birth control and fertility control. The devices or drugs used in contraception interfere with the normal process of sperm-ovum fertilization to prevent pregnancy.

Market Size and Key Findings

The APAC Contraceptives Market Analysis size stood at around USD 5.74 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 6.95% during the forecast period.

The Asia-Pacific contraceptive market is expected to reach at a CAGR of 6.95% during the forecast period 2020-2028.

Market Dynamics

Market Growth Drivers Analysis

The major factors attributing to the growth of the Asia-Pacific contraceptive drugs and devices market include the necessity to avoid unwanted pregnancies and their complications. The need to avoid unwanted pregnancies, especially in teenage women, is one of the major drivers for this market. It is also observed that more than half of the women identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain, and acne, as reasons for use. This is also one of the factors contributing to the growth of the market. The other factors helping the growth of the contraceptives market are the increasing incidence of STDs and the rapid increase in population in the region.

Market Restraints

In spite of all these advantages, factors such as lack of acceptance faced by contraceptives are impeding the market growth. Socio-cultural opposition for the use of contraceptives in countries having conservative populations is a major restraining factor. Moreover, lack of accessibility and misperceptions about the use of contraceptives are some of the challenges faced by the contraceptive industry.

COVID-19 impact on APAC Contraceptives Market

The COVID-19 epidemic has impacted negatively on healthcare services and technology around the world. It disrupted the demand and supply chain. Due to this pandemic, proper healthcare services and facilities were not available, as supply chains get disrupted, there were limited availability of contraceptives with product shortage & stock outs, lack of trained workers, and due to lack of personal protective equipment to provide safe services, due to the fear of Covid-19.

Competitive Landscape

Key Players

The Asia-Pacific contraceptive market has been segregated into various categories based on age groups, education, drugs & devices and end users. Companies such as Cooper Surgical, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries, Ltd., Apothecus Pharmaceutical Corporation, Pregna, Pfizer, Inc., Bayer AG, Melbea, SMB Corporation, Reckitt Benckiser PLC, Mayer Laboratories, Inc., Ocon Medical, Ltd., Okamoto Industries, Inc., Afaxys, Inc., Allergan, Inc. and Agile Therapeutics have been the leading manufacturers of contraceptives.

Products in Pipeline

In August 2018, Lupin Pharmaceuticals announced the launch of Drospirenone, Ethinyl Estradiol, and levomefolate Calcium tablets contraceptive drugs in the U.S.

In May 2018, Aurobindo Pharma launched MILI and TRI-MILI oral contraceptive tablets for use in women to avoid conception.

In April 2018, Mylan N.V., launched generic YAZ oral contraceptive drug for use by women to avoid unintentional pregnancy.

Notable Recent Deals

In November 2018, The population Control Council, Los Angeles Bio Medical Research Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and University of Washington School of Medicine launched first clinical study to test the efficacy and safety of a gel to be used by men for the prevention of unintended pregnancy.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

More than 218 million women living in developing countries do not want to become pregnant but do not use effective contraceptive methods. For some of them, access to contraception is limited; for others, available methods are not acceptable or affordable. The goal of the Contraceptive Technology Innovation (CTI) Initiative is to develop new and strategically important contraceptives, through a strong focus on global partnerships, that ensures wide access to quality, affordable and acceptable products for those most in need. The CTI Initiative, a project funded by the Bill & Melinda Gates Foundation, is in Phase 2 of implementation. Overall, the CTI Initiative aims to develop new contraceptive products that are safe, effective, low-cost, easy to use and appealing to women in greatest need.

Investment in contraceptive research to identify new products for women has been limited in the pharmaceutical industry relative to investment in drug development for other indications. Pharmaceutical R&D for male contraception was active in the 1990s but was abandoned over a decade ago. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has supported a contraceptive development program since 1969. Through a variety of programs including research grants and contracts, NICHD has developed a pipeline of new targets/products for male and female contraception. A number of lead candidates are under evaluation in the NICHD Contraceptive Clinical Trials Network (CCTN)
To Know More About COVID-19 Impact On APAC Contraceptives Market @ https://www.prudentmarkets.com/sample-request/141756/

APAC Contraceptives Market Analysis Segmentation

By Drug Type:

By drug type, the contraceptive pills industry is the largest within the segment owing to the widespread use of oral pills by women. This is mainly because they are proven to be highly effective up to 99% in preventing pregnancy. The condoms are the most commonly used contraceptive devices accounting for around two-thirds of the contraceptives market share in 2016. However, IUDs are gaining momentum and are expected to grow at a faster pace during the analysis period.

By Medical Devices:

Based on Medical Devices, the market is segmented condoms, intrauterine product (IUDs), vaginal rings, implants, patches, diaphragms, emergency contraceptives, sponges, and others. The condoms segment dominated the market in 2020 and intrauterine product (IUDs) segment is expected to be the fastest growing during the forecast period. Further, the condoms segment has been bifurcated into female condoms and male condoms. Similarly, the intrauterine product (IUDs) segment is bifurcated into hormonal IUDs and copper IUDs.

By End-Users:

Based on end user, the market is segmented into home care, and hospitals and clinics. The home care segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period.

By Country:

The contraceptives market of Asia Pacific includes countries such as China, Japan, India, Australia, South Korea and the rest of Asia Pacific. This region accounted for over fastest growing region of the global contraceptives market in 2020 owing to the rising awareness for unwanted pregnancies, increasing prevalence of STIs and the rapid rise in population in the region. Like any other country across the world, China is facing similar problems regarding sexually transmitted diseases. China has witnessed a rising epidemic of sexually transmitted infections (STIs), including HIV. Female sex workers (FSWs) and their clients, drug users, men who have sex with men (MSM), and migrant workers are groups having high risk of getting a STI. There are an around 2.8 to 4.5 million FSWs; 21.9 to 37.4 million clients of FSWs; 2 to 10 million MSM and 130 million migrant workers in China. Thus, this is likely to increase the demand for condoms in the country. Increasing awareness about sexually transmitted diseases is the major factor driving the growth of the APAC contraceptives market.

Highlighted Segments of APAC Contraceptives Market:

Industry Overview: The first section of the research study covers an overview of the global APAC Contraceptives Market, market status and prospects, and product range. In addition, it provides highlights of the major segments of the global Market, i.e., region, type, and application segments.

Competitive Analysis: This report illuminates important mergers and acquisitions, business expansion, product or service differences, market concentration, the competitive status of the global APAC Contraceptives Market, and market size by player.

Company Profiles and Key Data: This section covers companies profiling the major players in the global APAC Contraceptives Market based on the aforementioned revenue, products, business, and other factors.

Market size by type and application: In addition to providing an in-depth analysis of the industry size by type and application, this section provides research on top end users or consumers and potential applications.

Market Dynamics: This report covers the drivers, trends, and opportunities of the global APAC Contraceptives Market. This section also includes Porter's analysis of five forces.

Findings and Conclusions: It provides strong recommendations for new as well as established players for securing a position of strength in the global APAC Contraceptives Market.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141756/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global APAC Contraceptives Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global APAC Contraceptives Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the APAC Contraceptives market
Chapter 2: Exclusive Summary - the basic information of the APAC Contraceptives Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the APAC Contraceptives
Chapter 4: Presenting the APAC Contraceptives Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the APAC Contraceptives market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Why should you purchase this report?

-Prudent Markets provides the vital historical and analysis data of global APAC Contraceptives market.
-The report provides the entire assessment of the future market and altering market scenario or behavior.
-All the business decision could be backed through the several strategic business methodologies offered in the report.
-An extra edge in the competitive market could be obtained from this elaborative research report
-The report offers all the competitive landscape, growth drivers, applications, market dynamics, and other necessary details as well.

Purchase this report (Single User License) @ https://www.prudentmarkets.com/checkout/?id=141756&license_type=su

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the APAC Contraceptives Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.coma

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.